Gene · 684
Papers3,814
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1,141 to 1,160 of 3,814
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Interferon α2-Thymosin α1 Fusion Protein (IFNα2-Tα1): A Genetically Engineered Fusion Protein with Enhanced Anticancer and Antiviral Effect. | Materials (Basel) | 2021 | 34203928 | PubTator, text mining | PubMed |
| SARS-CoV-2: An Overview of Virus Genetics, Transmission, and Immunopathogenesis. | Int J Environ Res Public Health | 2021 | 34200934 | PubTator, text mining | PubMed |
| Examination of the APOBEC3 Barrier to Cross Species Transmission of Primate Lentiviruses. | Viruses | 2021 | 34200141 | PubTator, text mining | PubMed |
| A Sparse and Low-Rank Regression Model for Identifying the Relationships Between DNA Methylation and Gene Expression Levels in Gastric Cancer and the Prediction of Prognosis. | Genes (Basel) | 2021 | 34199440 | PubTator, text mining | PubMed |
| Cyanovirin-N Binds Viral Envelope Proteins at the Low-Affinity Carbohydrate Binding Site without Direct Virus Neutralization Ability. | Molecules | 2021 | 34199200 | PubTator, text mining | PubMed |
| CD101 genetic variants modify regulatory and conventional T cell phenotypes and functions. | Cell Rep Med | 2021 | 34195685 | PubTator, text mining | PubMed |
| Suppression of HSF1 activity by wildtype p53 creates a driving force for p53 loss-of-heterozygosity. | Nat Commun | 2021 | 34188043 | PubTator, text mining | PubMed |
| Spatial architecture of the immune microenvironment orchestrates tumor immunity and therapeutic response. | J Hematol Oncol | 2021 | 34172088 | PubTator, text mining | PubMed |
| Bioinformatic Analysis of Hepatocellular Carcinoma Cell Lines to the Efficacy of Nimotuzumab. | Int J Gen Med | 2021 | 34168487 | PubTator, text mining | PubMed |
| Multilevel systems biology analysis of lung transcriptomics data identifies key miRNAs and potential miRNA target genes for SARS-CoV-2 infection. | Comput Biol Med | 2021 | 34157472 | PubTator, text mining | PubMed |
| Stress Decreases Host Viral Resistance and Increases Covid Susceptibility in Embryonic Stem Cells. | Stem Cell Rev Rep | 2021 | 34155611 | PubTator, text mining | PubMed |
| Gender specific airway gene expression in COPD sub-phenotypes supports a role of mitochondria and of different types of leukocytes. | Sci Rep | 2021 | 34145303 | PubTator, text mining | PubMed |
| Meet the authors: Laura Martin-Sancho and Sumit K. Chanda. | Mol Cell | 2021 | 34143965 | PubTator, text mining | PubMed |
| Antiviral strategies targeting herpesviruses. | J Virus Erad | 2021 | 34141443 | PubTator, text mining | PubMed |
| Vpr counteracts the restriction of LAPTM5 to promote HIV-1 infection in macrophages. | Nat Commun | 2021 | 34140527 | PubTator, text mining | PubMed |
| Bcl6-Independent In Vivo Development of Functional Type 1 Classical Dendritic Cells Supporting Tumor Rejection. | J Immunol | 2021 | 34135058 | PubTator, text mining | PubMed |
| Dynamic innate immune response determines susceptibility to SARS-CoV-2 infection and early replication kinetics. | J Exp Med | 2021 | 34128960 | PubTator, text mining | PubMed |
| Identification and Verification of a 17 Immune-Related Gene Pair Prognostic Signature for Colon Cancer. | Biomed Res Int | 2021 | 34124251 | PubTator, text mining | PubMed |
| Inactivation of Latent HIV-1 Proviral DNA Using Clustered Regularly Interspaced Short Palindromic Repeats/Cas9 Treatment and the Assessment of Off-Target Effects. | Front Microbiol | 2021 | 34122355 | PubTator, text mining | PubMed |
| New perspective towards therapeutic regimen against SARS-CoV-2 infection. | J Infect Public Health | 2021 | 34118735 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/684/papers?page=58